XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Net sales $ 4,464,714 $ 4,092,526
Cost of goods sold 2,923,899 2,704,348
Gross profit 1,540,815 1,388,178
Operating expenses:    
Selling, administrative and other expenses 1,195,164 1,142,697
Depreciation and amortization 72,296 67,254
Provision for doubtful accounts 4,909 6,519
Restructuring costs 0 2,982
Total operating expenses 1,272,369 1,219,452
Non-operating (income) expense:    
Interest expense 19,062 20,965
Other (36,475) (12,832)
Total non-operating (income) expense (17,413) 8,133
Income before income taxes 285,859 160,593
Income taxes 68,149 38,247
Net income from continuing operations 217,710 122,346
Net income from discontinued operations 0 14,189
Net income $ 217,710 $ 136,535
Dividends declared per common share (usd per share) $ 0.8150 $ 0.7900
Basic earnings per share:    
Continuing operations (in dollars per share) 1.51 0.84
Discontinued operations (in dollars per share) 0 0.10
Basic earnings (loss) per share (in dollars per share) 1.51 0.94
Diluted earnings per share:    
Continuing operations (in dollars per share) 1.50 0.84
Discontinued operations (in dollars per share) 0 0.10
Diluted earnings (loss) per share (in dollars per share) $ 1.50 $ 0.94
Weighted average common shares outstanding (in shares) 144,413 145,052
Dilutive effect of stock options and non-vested restricted stock awards (in shares) 887 571
Weighted average common shares outstanding - assuming dilution (in shares) 145,300 145,623